T1	Disease 62 67	NAFLD
#1	AnnotatorNotes T1	DOID:0080208
T10	Disease 492 494	DM
T11	Disease 612 627	hepatosteatosis
T12	Disease 650 655	NAFLD
T13	Disease 660 678	insulin resistance
#5	AnnotatorNotes T13	D007333
T15	Disease 780 787	Obesity
#6	AnnotatorNotes T15	DOID:9970
T17	Disease 845 850	NAFLD
T19	Disease 948 953	NAFLD
T2	Disease 104 109	NAFLD
T20	Disease 971 978	obesity
T21	Disease 983 987	T2DM
#11	AnnotatorNotes T21	DOID:9352
T23	Disease 1137 1144	obesity
T24	Disease 1149 1153	T2DM
T26	Chemical 1240 1249	aspartate
T28	Chemical 1267 1274	alanine
T31	Chemical 1337 1346	aspartate
T32	Disease 1435 1440	NAFLD
T36	Disease 1591 1598	obesity
T37	Disease 1603 1607	T2DM
T39	Disease 1686 1691	NAFLD
T41	Disease 1808 1819	fatty liver
#25	AnnotatorNotes T41	DOID:9452
T5	Disease 225 244	fatty liver disease
#26	AnnotatorNotes T5	DOID:9452
T8	Disease 384 401	hepatic steatosis
#27	AnnotatorNotes T8	DOID:9452
T9	Disease 480 487	obesity
#28	AnnotatorNotes T9	DOID:9970
T3	Gene-Protein 30 36	FGF 19
#2	AnnotatorNotes T3	HGNC:3675
T4	Gene-Protein 315 323	FGF15/19
#3	AnnotatorNotes T4	not found,HGNC:3675
T6	Biomarker 30 36	FGF 19
#4	AnnotatorNotes T6	C117476
R1	Association Arg1:T6 Arg2:T1	
T7	Gene-Protein 828 833	FGF19
T14	Biomarker 114 152	increased endoplasmic reticulum stress
R2	Association Arg1:T14 Arg2:T2	
T16	Biomarker 169 205	chronic endoplasmic reticulum stress
R3	Association Arg1:T16 Arg2:T5	
T18	Biomarker 303 328	Lack of the FGF15/19 gene
R4	Association Arg1:T18 Arg2:T8	
T27	Gene-Protein 441 447	FGF 19
T33	Gene-Protein 578 585	insulin
T34	Gene-Protein 660 667	insulin
T35	Gene-Protein 715 720	FGF19
T38	Chemical 754 759	lipid
T40	Biomarker 686 720	impaired hepatic response to FGF19
T42	Biomarker 818 840	decreased FGF19 levels
T43	Collection 650 678	NAFLD and insulin resistance
R5	Association Arg1:T40 Arg2:T43	
T44	Gene-Protein 924 930	FGF 19
T22	Gene-Protein 1502 1508	FGF 19
T45	Gene-Protein 1636 1641	FGF19
T46	Biomarker 1626 1641	decreased FGF19
R7	Association Arg1:T46 Arg2:T39	
T49	Gene-Protein 1754 1760	FGF 19
T50	GeneFamily 1240 1266	aspartate aminotransferase
#8	AnnotatorNotes T50	not found
T51	Gene-Protein 1267 1291	alanine aminotransferase
#9	AnnotatorNotes T51	HGNC:4552
T52	Gene-Protein 1337 1363	aspartate aminotransferase
#10	AnnotatorNotes T10	DOID:9351
T29	Biomarker 1754 1781	FGF 19 levels â‰¤ 49.97 pg/mL
#12	AnnotatorNotes T11	DOID:9452
T53	Biomarker 1230 1297	including aspartate aminotransferase/alanine aminotransferase ratio
T54	Biomarker 1321 1331	BARD score
T55	Biomarker 1337 1387	aspartate aminotransferase to platelet ratio index
T56	Biomarker 1299 1319	NAFLD fibrosis score
T57	Collection 1207 1387	liver fibrosis scores, including aspartate aminotransferase/alanine aminotransferase ratio, NAFLD fibrosis score, BARD score, and aspartate aminotransferase to platelet ratio index
T25	Biomarker 1207 1228	liver fibrosis scores
R8	Association Arg1:T57 Arg2:T32	
T30	Collection 1496 1566	lower FGF 19 levels, lower body weight, and lower waist circumferences
T58	Collection 1591 1607	obesity and T2DM
R9	Association Arg1:T30 Arg2:T58	
R10	Association Arg1:T29 Arg2:T41	
#13	AnnotatorNotes T35	HGNC:3675
T47	Biomarker 261 294	increased FFA flux into the liver
T48	Drug 500 513	high-fat diet
#14	AnnotatorNotes T48	D059305
T59	Biomarker 1496 1515	lower FGF 19 levels
T60	Biomarker 1517 1534	lower body weight
T61	Biomarker 1540 1566	lower waist circumferences
#7	AnnotatorNotes T33	HGNC:6081
